Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure
Recruiting · NCT06836687 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital Marburg
View the official record on ClinicalTrials.gov →What this trial is about
The present study is a prospective study on the development of seizure frequency, medication adherence, quality of life and cognitive performance after a first epileptic seizure using the new diagnostic criteria for epilepsy of the International League Against Epilepsy of 2014 at the time of diagnosis.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Completion of the 18th year of life
- first epileptic seizure
- Ability to understand the patient information and to give written consent
- Written consent for voluntary participation in the study
Exclusion criteria
- Chronic drug or alcohol abuse in the last two years
Where it is running
1 location listed.
- c/o Klinik für Neurologie - Marburg, Hesse, Germany